Same Indication

Ipilimumab vs Metronidazole

Ipilimumab vs Metronidazole: Overview

This comparison examines the pharmacological differences between Ipilimumab and Metronidazole.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Metronidazole: Forms cytotoxic free radicals that damage bacterial DNA.

Pharmacokinetics

Half-life: Ipilimumab β€” 14.7 days; Metronidazole β€” 8 hours.

Chemical Properties

Molecular Formula: Metronidazole β€” C6H9N3O3.

Molecular Weight: Metronidazole β€” 171.1540 g/mol.

Type: Ipilimumab β€” Antibody; Metronidazole β€” Small molecule.